首页> 外文OA文献 >Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: Homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry
【2h】

Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: Homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry

机译:开发一种新的生化检测方法,用于诊断和监测越南神经母细胞瘤:气相色谱 - 质谱法测定Homovanillic和vanillylmandelic acid

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectivesbr The aim of this study was to develop an accurate robust testing method to simultaneously measure urine levels of HVA and VMA using gas chromatography mass spectrometry (GCMS) and to establish age-specific reference intervals of HVA and VMA in random urines for Vietnamese children.p/pDesign and methodsbr The assay for urinary HVA and VMA was developed based on a classical urinary organic acid profiling method. Briefly, this incorporated 3-phenyl butyric acid as the internal standard and liquid–liquid extraction with ethyl acetate followed by derivatization with BSTFA. The Agilent 7890A GC and 5975C Mass Selective Detector in single ion monitoring mode was used for analysis.p/p Reference intervals were developed from random urine samples collected from 634 disease free Vietnamese children and compared to 50 known neuroblastoma patient samples. Results were reported relative to creatinine concentration. Age related 95% reference intervals for urinary HVA and VMA were estimated from sample quantiles. The analytes (expressed as analyte/creatinine ratios) diagnostic values were determined by calculating the related sensitivity, specificity and likelihood ratios.p/p Resultsbr HVA and VMA were linear to at least 193 and 221 μmol/L, respectively. The limit of quantitation for both analytes was 0.9 μmol/L. Using the bi-level control (n = 15), the within-batch coefficients of variations (CVs) were less than 3% for both analytes across the assay range. The between-batch CVs (n = 20 over three months), were 3.6% at 11 μmol/L and 2.1% at 88 μmol/L for HVA, 6.6% at 18.2 μmol/L and 2.6% at 90.6 μmol/L for VMA.p/p Vietnamese age related reference intervals were established for urinary HVA and VMA per creatinine. HVA for children 6 months (n = 91) was 5.3–37.0 μmol/mmol; 6 months to 1 year (n = 141) was 2.7–27.7 μmol/mmol; 1 to 5 years (n = 139) was 3.4–17.9 μmol/mmol; 6 to 10 years (n = 136) was 2.7–8.8 μmol/mmol; and 11 to 15 years (n = 127) was 1.1–9.4 μmol/mmol. VMA for children 6 months was 1.8–12.2 μmol/mmol; 6 months to 1 year was 1.5–9.3 μmol/mmol; 1 to 5 years was 1.9–7.8 μmol/mmol; 6 to 10 years was 1.6–5.1 μmol/mmol; and 11 to 15 years was 0.9–6.3 μmol/mmol.p/p Conclusionsbr A robust testing method for simultaneous quantitation of urinary HVA and VMA by GCMS was developed. This method is accurate, precise and fit for its clinical purpose and suitable for developing countries. Age-related reference intervals of urinary HVA and VMA were established for Vietnamese children and the intervals declined progressively with increasing age for each analyte.
机译:目的这项研究的目的是开发一种准确可靠的测试方法,使用气相色谱质谱(GCMS)同时测量HVA和VMA的尿液水平,并确定随机尿中HVA和VMA的年龄特定参考区间越南儿童。> 设计与方法尿液HVA和VMA的测定是基于经典的尿液有机酸分析方法开发的。简而言之,将3-苯基丁酸作为内标物,并先后用乙酸乙酯进行液-液萃取和BSTFA衍生化。使用单离子监测模式的Agilent 7890A GC和5975C质量选择检测器进行分析。> 参考间隔是根据从634名无病的越南儿童中收集的随机尿液样品得出的,并与50个已知的成神经细胞瘤患者样品进行了比较。报告了相对于肌酐浓度的结果。从样本分位数中估算出与年龄相关的95%的尿HVA和VMA参考间隔。通过计算相关的灵敏度,特异性和似然比,确定分析物(以分析物/肌酐比值表示)的诊断值。> 结果 HVA和VMA线性至少为193和221μmol/ L , 分别。两种分析物的定量限均为0.9μmol/ L。使用双级对照(n = 15),在整个测定范围内,两种分析物的批内变异系数(CV)均小于3%。批间CV(三个月内n = 20)在HVA时分别为11%/ 3.6μ%和88μmol/ L时2.1%,VMA 18.6μmol/ L时为6.6%和90.6μmol/ L时为2.6% 。> 为每个肌酐确定了尿HVA和VMA的越南年龄相关参考区间。 <6个月儿童(n = 91)的HVA为5.3-37.0μmol/ mmol; <1年(n = 141)的6个月为2.7-27.7μmol/ mmol; 1至5年(n = 139)为3.4-17.9μmol/ mmol; 6至10年(n = 136)为2.7–8.8μmol/ mmol; 11至15年(n = 127)为1.1–9.4μmol/ mmol。 <6个月儿童的VMA为1.8-12.2μmol/ mmol; <1年的6个月为1.5–9.3μmol/ mmol; 1至5年为1.9–7.8μmol/ mmol; 6至10年为1.6–5.1μmol/ mmol;结论建立了一套可靠的GCMS同时定量测定尿HVA和VMA的检测方法。<11> 15岁<0.9-6.3μmol/ mmol。> 该方法准确,精确并适合其临床目的,适合发展中国家。为越南儿童建立了与年龄相关的尿液HVA和VMA的参考间隔,每种分析物的间隔随着年龄的增长而逐渐降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号